Effect of Adding Interferential Current to Pelvic Floor Muscle Training on Vaginismus
Launched by CAIRO UNIVERSITY · Jun 27, 2024
Trial Information
Current as of August 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how adding a treatment called interferential current to pelvic floor muscle training can help women with vaginismus, a condition that can make penetration painful or impossible. The study will involve women who have been married for 1 to 12 months and experience significant pain during intercourse. To be eligible, participants should have a pain level of 4 or higher on a scale where 0 means no pain and 10 means the worst pain imaginable. Additionally, they should lead a mostly inactive lifestyle and have been diagnosed by a gynecologist.
If you or someone you know is considering this trial, it's important to note that it is not yet recruiting participants. The study is specifically for women who do not have other serious gynecological issues or conditions that affect their muscles or nerves. Participants will engage in pelvic floor muscle training combined with interferential current treatment, which aims to improve their symptoms and overall comfort. This trial represents a potential new approach to help women experiencing challenges with vaginismus.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Women suffer from primary vaginismus with a duration of marriage ranging from 1 to 12 months. They are diagnosed and referred by the gynecologist.
- • 2. Their pain level is ≥ 4 on the visual analogue scale.
- • 3. They have a sedentary lifestyle.
- Exclusion Criteria:
- • 1. Vaginismus requiring surgical treatment.
- • 2. Any gynecological diseases such as pelvic organ prolapse, vulvar vestibulitis, vulvar pain, clitorodynia, vulvar dysesthesia, or any pelvic inflammatory diseases.
- • 3. Lower urinary tract infection.
- • 4. Husband with sexual dysfunction that prevents penetration.
- • 5. Diseases involving nerves and muscles, such as myasthenia gravis.
- • 6. Severe psychiatric disorder or cognitive relegation.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Doaa A. Osman, PHD
Study Chair
Department of Women's Health, Faculty of Physical Therapy, Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported